HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junctional Adhesion Molecules

A family of membrane glycoproteins localized to TIGHT JUNCTIONS that contain two extracellular Ig-like domains, a single transmembrane segment, and a cytoplasmic tail of variable length.
Also Known As:
Junction Adhesion Molecule; Junctional Adhesion Molecule; Adhesion Molecule, Junction; Adhesion Molecule, Junctional; Adhesion Molecules, Junctional
Networked: 89 relevant articles (2 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Aurrand-Lions, Michel: 6 articles (10/2018 - 08/2009)
2. Imhof, Beat A: 5 articles (01/2018 - 08/2009)
3. Pichiorri, Flavia: 3 articles (06/2017 - 12/2014)
4. Havran, Wendy L: 2 articles (10/2021 - 09/2010)
5. Witherden, Deborah A: 2 articles (10/2021 - 09/2010)
6. Xue, Fei: 2 articles (01/2021 - 01/2019)
7. Yang, Jianmin: 2 articles (01/2021 - 01/2019)
8. Lathia, Justin D: 2 articles (11/2020 - 01/2014)
9. Naik, Ulhas P: 2 articles (11/2020 - 01/2014)
10. Beiras-Fernandez, Andres: 2 articles (02/2020 - 02/2016)

Related Diseases

1. Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/01/2018 - "Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis."
11/13/2009 - "However, it is down-regulated by inflammatory cytokines, including tumor necrosis factor (TNF)-alpha, IL-17, interferon-gamma, IL-1beta, and IL-6 in vitro, and is also reduced in active multiple sclerosis (MS) lesions and in the inflamed spinal cord of experimental autoimmune encephalomyelitis, an animal model of MS. Furthermore, IL-25 restores the reduced expression of tight junction proteins, occludin, junction adhesion molecule, and claudin-5, induced by TNF-alpha in BCECs and consequently repairs TNF-alpha-induced blood-brain barrier (BBB) permeability. "
01/01/2021 - ": 22q11DS 22q11 deletion syndrome; ACKR1 atypical chemokine receptor 1; AD Alzheimer disease; AQP aquaporin; ATP adenosine triphosphate; Aβ amyloid β; BAC bacterial artificial chromosome; BBB blood-brain barrier; C/EBP-α CCAAT/enhancer-binding protein α; cAMP cyclic adenosine monophosphate (or 3',5'-cyclic adenosine monophosphate); CD cluster of differentiation; CNS central nervous system; DSRED discosoma red; EAE experimental autoimmune encephalomyelitis; ECV304 immortalized endothelial cell line established from the vein of an apparently normal human umbilical cord; EGFP enhanced green fluorescent protein; ESAM endothelial cell-selective adhesion molecule; GLUT-1 glucose transporter 1; GVB gut-vascular barrier; H2B histone H2B; HAPP human amyloid precursor protein; HEK human embryonic kidney; JACOP junction-associated coiled coil protein; JAM junctional adhesion molecules; LYVE1 lymphatic vessel endothelial hyaluronan receptor 1; MADCAM1 mucosal vascular addressin cell adhesion molecule 1; MAPK mitogen-activated protein kinase; MCAO middle cerebral artery occlusion; MMP metalloprotease; MS multiple sclerosis; MUPP multi-PDZ domain protein; PATJ PALS-1-associated tight junction protein; PDGFR-α platelet-derived growth factor receptor α polypeptide; PDGFR-β platelet-derived growth factor receptor β polypeptide; RHO rho-associated protein kinase; ROCK rho-associated, coiled-coil-containing protein kinase; RT-qPCR real time quantitative polymerase chain reactions; PDGFR-β soluble platelet-derived growth factor receptor, β polypeptide; T24 human urinary bladder carcinoma cells; TG2576 transgenic mice expressing the human amyloid precursor protein; TNF-α tumor necrosis factor α; WTwild-type; ZO zonula occludens."
2. B-Cell Lymphoma (Lymphoma, B Cell)
3. Herpes Zoster
4. Hypothermia
5. Critical Illness (Critically Ill)

Related Drugs and Biologics

1. Occludin
2. Proteins (Proteins, Gene)
3. Claudin-1
4. Tight Junction Proteins
5. Claudins
6. Messenger RNA (mRNA)
7. Biomarkers (Surrogate Marker)
8. cadherin 5
9. MARVEL Domain Containing 2 Protein
10. HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)

Related Therapies and Procedures

1. Rewarming
2. Ligation
3. Immunotherapy